<?xml version="1.0" encoding="UTF-8"?>



	
		















            





<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>Deloitte United Kingdom English Life Sciences headlines</title>
    <link>http://www.deloitte.com/rss/en_GB/uk/37f160b0fb431210VgnVCM200000bb42f00aRCRD.rss</link>
    <description>Featured Life Sciences headlines from Deloitte United Kingdom</description>
    <language>en</language>
    <pubDate>Tue, 12 May 2009 00:00:00 GMT</pubDate>
    <lastBuildDate>Mon, 01 Jun 2009 17:38:41 GMT</lastBuildDate>
    <item>
      <title>Deloitte report: £4.5 billion spent annually on end-of-life care, but delivery could be improved</title>
      <link>http://www.deloitte.com/view/en_GB/uk/b58460c1695d8410VgnVCM1000003256f70aRCRD.htm</link>
      <description>At least £4.5 billion is spent each year in England caring for those at the end of their lives, according to a report by the Deloitte Centre for Health Solutions, an independent research arm of the business advisory firm.</description>
      <pubDate>Sun, 05 Oct 2014 19:01:14 GMT</pubDate>
      <guid isPermaLink="false">758460c1695d8410VgnVCM1000003256f70a____</guid>
    </item>
    <item>
      <title>Deloitte: is life science R&amp;D earning its investment?</title>
      <link>http://www.deloitte.com/view/en_GB/uk/385541f15f2b2410VgnVCM3000003456f70aRCRD.htm</link>
      <description>The largest pharmaceutical companies have performed well in terms of bringing new products to market but are struggling with diminishing returns on investment according to a study by Deloitte, the business advisory firm, and Thomson Reuters.</description>
      <pubDate>Mon, 02 Dec 2013 19:01:29 GMT</pubDate>
      <guid isPermaLink="false">085541f15f2b2410VgnVCM3000003456f70a____</guid>
    </item>
    <item>
      <title>Spending Review: Deloitte comments on health measures</title>
      <link>http://www.deloitte.com/view/en_GB/uk/703ce9afe208f310VgnVCM2000003356f70aRCRD.htm</link>
      <description>Health remains a priority for the Government, which means the budget is protected, but in real terms will continue to fall in a time of relentlessly increasing demand.</description>
      <pubDate>Wed, 26 Jun 2013 09:16:10 GMT</pubDate>
      <guid isPermaLink="false">403ce9afe208f310VgnVCM2000003356f70a____</guid>
    </item>
    <item>
      <title>Primary Care: Today and Tomorrow - Improving general practice by working differently</title>
      <link>http://www.deloitte.com/view/en_GB/uk/bb6e38f609817310VgnVCM3000001c56f00aRCRD.htm</link>
      <description>The report highlights the need for general practice to work differently to cope effectively with the increasing demands it faces.  This will be especially pertinent as GPs take on the role of commissioners of local healthcare services.</description>
      <pubDate>Fri, 04 May 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">8b6e38f609817310VgnVCM3000001c56f00a____</guid>
    </item>
    <item>
      <title>Pharmaceutical R&amp;D is healthy but needs to be fitter, according to new analysis from Deloitte and Thomson Reuters</title>
      <link>http://www.deloitte.com/view/en_GB/uk/70a633b3962ac210VgnVCM1000001a56f00aRCRD.htm</link>
      <description>New analysis into the value generated by the research and development (R&amp;D) carried out by leading pharmaceutical companies indicates that new approaches are needed if R&amp;D is to be able to pay its way.</description>
      <pubDate>Wed, 01 Dec 2010 10:37:52 GMT</pubDate>
      <guid isPermaLink="false">60a633b3962ac210VgnVCM1000001a56f00a____</guid>
    </item>
    <item>
      <title>Deloitte life sciences &amp; health care team celebrates corporate finance award success</title>
      <link>http://www.deloitte.com/view/en_GB/uk/2f1c4f0d85df8210VgnVCM100000ba42f00aRCRD.htm</link>
      <description>The corporate finance life sciences &amp; health care team at Deloitte, the business advisory firm, is celebrating after being named Corporate Financier of the Year at this year’s HealthInvestor Awards ceremony.</description>
      <pubDate>Thu, 03 Jun 2010 07:19:56 GMT</pubDate>
      <author />
      <guid isPermaLink="false">1f1c4f0d85df8210VgnVCM100000ba42f00a____</guid>
    </item>
    <item>
      <title>Deloitte: Global economic downturn likely to change face of life sciences industries for years to come</title>
      <link>http://www.deloitte.com/view/en_GB/uk/6fa18b0ecc868210VgnVCM200000bb42f00aRCRD.htm</link>
      <description>Curbing costs in response to the global economic downturn, as well as the continuing capital crunch, is likely to have a long-term impact on the life sciences industries.</description>
      <pubDate>Wed, 05 May 2010 10:39:21 GMT</pubDate>
      <author />
      <guid isPermaLink="false">5fa18b0ecc868210VgnVCM200000bb42f00a____</guid>
    </item>
    <item>
      <title>Improving quality of health care is a key factor in determining support for political candidates, says Deloitte survey</title>
      <link>http://www.deloitte.com/view/en_GB/uk/14a074db59cf7210VgnVCM200000bb42f00aRCRD.htm</link>
      <description>A survey indicates that 61% of UK adults see improving the quality of care provided by doctors and hospitals as highly important in determining their support for political candidates.</description>
      <pubDate>Wed, 14 Apr 2010 19:01:41 GMT</pubDate>
      <author />
      <guid isPermaLink="false">25e448f148cf7210VgnVCM200000bb42f00a____</guid>
    </item>
    <item>
      <title>Deloitte strengthens Life Sciences &amp; Health Care practice with key appointments</title>
      <link>http://www.deloitte.com/view/en_GB/uk/72986e2278b46210VgnVCM200000bb42f00aRCRD.htm</link>
      <description>Deloitte, the business advisory firm, has announced three new senior appointments to its burgeoning Life Sciences &amp; Health Care practice.</description>
      <pubDate>Wed, 20 Jan 2010 06:55:24 GMT</pubDate>
      <author />
      <guid isPermaLink="false">62986e2278b46210VgnVCM200000bb42f00a____</guid>
    </item>
    <item>
      <title>Deloitte comments on the introduction of the ‘Patent Box’</title>
      <link>http://www.deloitte.com/view/en_GB/uk/9c80260c88475210VgnVCM200000bb42f00aRCRD.htm</link>
      <description>"The Chancellor announced the introduction of a Patent Box, under which patent income will be subject to corporation tax at the reduced rate of 10%"</description>
      <pubDate>Wed, 09 Dec 2009 12:57:17 GMT</pubDate>
      <author />
      <guid isPermaLink="false">db80260c88475210VgnVCM200000bb42f00a____</guid>
    </item>
  </channel>
</rss>










	
	
